[{"innerBlocks":[],"name":"core\/freeform","postId":793,"blockType":{"name":"core\/freeform","keywords":[],"attributes":{"content":{"type":"string","source":"raw"},"lock":{"type":"object"}},"providesContext":[],"usesContext":[],"selectors":[],"supports":{"className":false,"customClassName":false,"reusable":false},"styles":[],"variations":[],"apiVersion":3,"title":"Classic","description":"Use the classic WordPress editor.","category":"text"},"originalContent":"Despite the fact that physician use of prescription drug monitoring programs has dramatically increased, the use of these state-run databases isn\u2019t curtailing the opioid crisis.

That\u2019s the sobering reality according to Susan Bailey, MD, president-elect of the American Medical Association.

While opioid prescriptions decreased 33 percent between 2013 and 2018, including more than 12 percent between 2017 and 2018, this progress \u201chas not led to an overall reduction in mortality or a measurable increase in positive patient outcomes,\u201d Bailey said in bleak testimony on Wednesday to a House committee.

In fact, Bailey testified that \u201cthe nation\u2019s epidemic of opioid-related overdoses and deaths continues to worsen.\u201d

Also See<\/b>: Questions swirl on the utility of current PDMP role in opioid crisis<\/a>

In her testimony, Bailey referenced the AMA\u2019s recently released Opioid Task Force 2019 Progress Report<\/a>, which found that physicians are leveraging PDMPs more than ever. PDMPs are designed to track prescriptions written for controlled substances by recording patient opioid prescribing histories to flag suspicious prescribing activities.

According to Bailey\u2019s testimony, the use of PDMPs increased to more than 450 million queries in 2018, a 56 percent increase from 2017 and a 651 percent increase from 2014. In addition, she noted that almost 2 million physicians and other healthcare professionals are registered to use PDMPs, a 290 percent increase from 2014.

Nonetheless, Bailey quoted AMA President Patrice Harris, MD, chair of AMA\u2019s Opioid Task Force, who said that \u201cwhile physicians must continue to demonstrate leadership by taking action, it is clear that these significant reductions in opioid prescribing, increases in prescription drug monitoring program use and taking more education\u2014by themselves\u2014will not stop people from dying.\u201d

When it comes to PDMPs, the AMA has urged states to take action to improve integration with electronic health record systems and daily workflow at the point of care, thereby eliminating the requirement for providers to log in to a separate system and manage a separate log in\u2014which the physician group says disrupts doctors\u2019 workflows to query the PDMP.","saveContent":"Despite the fact that physician use of prescription drug monitoring programs has dramatically increased, the use of these state-run databases isn\u2019t curtailing the opioid crisis.

That\u2019s the sobering reality according to Susan Bailey, MD, president-elect of the American Medical Association.

While opioid prescriptions decreased 33 percent between 2013 and 2018, including more than 12 percent between 2017 and 2018, this progress \u201chas not led to an overall reduction in mortality or a measurable increase in positive patient outcomes,\u201d Bailey said in bleak testimony on Wednesday to a House committee.

In fact, Bailey testified that \u201cthe nation\u2019s epidemic of opioid-related overdoses and deaths continues to worsen.\u201d

Also See<\/b>: Questions swirl on the utility of current PDMP role in opioid crisis<\/a>

In her testimony, Bailey referenced the AMA\u2019s recently released Opioid Task Force 2019 Progress Report<\/a>, which found that physicians are leveraging PDMPs more than ever. PDMPs are designed to track prescriptions written for controlled substances by recording patient opioid prescribing histories to flag suspicious prescribing activities.

According to Bailey\u2019s testimony, the use of PDMPs increased to more than 450 million queries in 2018, a 56 percent increase from 2017 and a 651 percent increase from 2014. In addition, she noted that almost 2 million physicians and other healthcare professionals are registered to use PDMPs, a 290 percent increase from 2014.

Nonetheless, Bailey quoted AMA President Patrice Harris, MD, chair of AMA\u2019s Opioid Task Force, who said that \u201cwhile physicians must continue to demonstrate leadership by taking action, it is clear that these significant reductions in opioid prescribing, increases in prescription drug monitoring program use and taking more education\u2014by themselves\u2014will not stop people from dying.\u201d

When it comes to PDMPs, the AMA has urged states to take action to improve integration with electronic health record systems and daily workflow at the point of care, thereby eliminating the requirement for providers to log in to a separate system and manage a separate log in\u2014which the physician group says disrupts doctors\u2019 workflows to query the PDMP.","order":0,"get_parent":{},"attributes":[],"attributesType":{"content":{"type":"string","source":"raw"},"lock":{"type":"object"}},"dynamicContent":""}]

Doctors increasingly use PDMPs, but opioid impact still rising

More for you